Patent ID: 7176211

Claim:
A method for treating a condition selected from the group of prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis in a subject in need thereof comprising administering to the subject a pharmaceutically effective amount of a compound represented by the following structure: or a stereoisomer or pharmaceutically acceptable salt thereof, wherein: R 1a , R 1b and R 1c are the same or different and independently hydrogen, halogen, C 1-4 alkyl, hydroxy or alkoxy, or R 1a and R 1b taken together form —OCH 2 O— or —OCH 2 CH 2 —; R 2a and R 2b are the same or different and independently hydrogen, halogen, trifluoromethyl, cyano or —SO 2 CH 3 ; R 3 is hydrogen or methyl; R 4 is phenyl or C 3-7 alkyl; R 5 is hydrogen or C 1-4 alkyl; R 6 is -COOH or an acid isostere; and X is C 1-6 alkanediyl optionally substituted with from 1 to 3 C 1-6 alkyl groups.